Gefitinib (250mg)
Gefticip Tablet is used in the treatment of non-small cell lung cancer in patients with abnormal epidermal growth factor receptor (EGFR) genes and no previous cancer treatment.
Tablet
Gefticip Tablet is an anti-cancer medication used to treat non-small cell lung cancer that has spread to other parts of the body. It works by blocking the action of the abnormal protein that signals cancer cells to multiply, helping to stop or slow the spread of cancer cells.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Gefticip Tablet may be taken with or without food, but it is better to take it at a fixed time.
No common side effects listed
Gefticip Tablet is an anti-cancer medication that works by blocking the action of the abnormal protein that signals cancer cells to multiply, helping to stop or slow the spread of cancer cells.
Take it with or without food preferably at the same time each day Do not take antacids 2 hours before or 1 hour after taking this medicine Drink plenty of fluids and inform your doctor if diarrhea doesn't stop or if blood is found in the stools Use a reliable contraceptive method to prevent pregnancy while taking this medicine and for a month after stopping it Inform your doctor if you develop ulceration in your mouth, changes in your vision, or if you experience a worsening cough, shortness of breath, or breathing difficulties Your doctor may want you to have regular blood tests to monitor your liver function while taking this medicine